Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Abeona Therapeutics Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 55 | 65 | +10 |
| Shares | 28.8M | 30.6M | +1.87M (+6.5%) |
| Value | $181.7M | $170.4M | −$11.3M (−6.2%) |
New holders (14)
Institutions that held Abeona Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 134,028 | $746.5K | 0.00% |
| Wellington Management Group LLP | 93,289 | $519.6K | 0.00% |
| Trexquant Investment LP | 68,516 | $381.6K | 0.00% |
| Omers Administration Corp | 65,045 | $362.3K | 0.00% |
| UBS Group AG | 62,997 | $350.9K | 0.00% |
| Schonfeld Strategic Advisors LLC | 61,266 | $341.3K | 0.00% |
| Balyasny Asset Management LLC | 34,128 | $190.1K | 0.00% |
| Oxford Asset Management LLP | 21,121 | $117.6K | 0.05% |
| Squarepoint Ops LLC | 12,028 | $67.0K | 0.00% |
| Twinbeech Capital LP | 10,425 | $58.1K | 0.00% |
| Group One Trading, L.P. | 4,900 | $27.3K | 0.00% |
| R Squared Ltd | 4,160 | $23.2K | 0.02% |
| SBI Securities Co., Ltd. | 217 | $1.21K | 0.00% |
| BNP Paribas Arbitrage, SA | 1 | $6 | 0.00% |
Sold out (4)
Institutions that held Abeona Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| XTX Topco Ltd | 25,301 | $159.9K |
| ADAR1 Capital Management, LLC | 24,322 | $153.7K |
| Bank of Montreal | 14,300 | $84.8K |
| Wells Fargo & Company | 60 | $379 |